High levels of pipeline activity are being observed in Batten Disease treatment during 2019. Clinical development activities are being undertaken by more than 10 companies including Abeona Therapeutics Inc, Amicus Therapeutics, Blue Turtle Bio Technologies Inc, Circumvent Pharmaceuticals Inc, Collaborations Pharmaceuticals Inc and others.
A Significant contribution to the Batten Disease pipeline is being observed from emerging companies opting for new approaches to clinical development strategy. The early stage and late-stage Batten Disease pipeline included 13 compounds, driven by increasing number of targeted therapies. Progress is being made in accelerating compounds into advanced stages. However, fluctuating trends are being observed in average duration across three phases.
Increased understanding of underlying causes of Batten Disease condition and increased access to investments is encouraging growth of Batten Disease drug pipeline. However, despite high levels of pipeline activity, increasing clinical trial costs and decreasing drug approval rates is requiring companies to focus more on understanding clinical development pipeline compounds.
The research study is structured to provide clear and actionable insights into Batten Disease drug pipeline for companies to optimize spending levels by understanding competition, their pipeline products and prospect of further advances over the next few years.
The report addresses the discovery, research and pre-clinical stage active Batten Disease therapeutic candidates. Further, drugs in clinical stage including phase 1, phase 2, phase 3 and pre-registration phases are also analyzed.
The current report examines the current Batten Disease pipeline along with current development status, regulatory progress, mechanism of action, route of administration, collaborating companies, sponsors, molecule type, and research/discovery details.
In addition to drug overview, recent developments, the report also provides mechanism of action, Pre-clinical trial details and Clinical trial details for each of the drug candidates of Batten Disease. Further, orphan drug status, fast track designation, grants awarded and other special status for Batten Disease pipeline compounds are also included.
This study was produced independently by VPAResearch from our proprietary databases, primarily to assist users to develop in-depth understanding of 2019 Batten Disease pipeline and formulate effective research and development strategies.
Our integrated data reports are built through robust research methodology to ensure our users can build on the insights and data accuracy for their expansion plans. Both primary and secondary research methods are used with stringent quality checks at each stage to evaluate trends, analysis and forecasts.
Scope of the Research
Batten Disease Pipeline candidates- - Pre-clinical Phase: Discovery, research, pre-clinical
- Early Phase: Phase 1 and Phase 2 Batten Disease drugs
- Late phase: Phase 3 and in-approval Batten Disease drugs
Companies involved in the Pipeline- - Company overview
- Batten Disease therapeutic treatment activities
Details for each Batten Disease drug candidate- - Snapshot
- Drug Name
- Alternative Names
- Molecule Type
- Orphan Drug Status
- Drug Overview
- Mechanism of Action
- Current Status
- Trial Details
Other details - Pre-clinical trials for each drug candidate
- Clinical trials for each drug candidate
Recent Batten Disease therapeutic candidates, clinical trials, investments, grants, partnerships, licenses, awards and other news
Our reports have been used by over 10K customers, including:
Orexin Receptor Type 2 - Drugs In Development, 2021 Summary According to the recently published report ’Orexin Receptor Type 2 - Drugs In Development, 2021’; Orexin Receptor Type 2 (Hypocretin Receptor Type 2 or HCRTR2) pipeline Target constitutes close to 16 molecules. Out of which approximately...
251 pages •
By Asia Market Information & Development Company
• Aug 2021
China’s demand for Mental Illness Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer...
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Sleep Market Report
The sleep market by revenue is expected to grow at a CAGR of 6.11% during the period 2020–2026.
Several research studies and government programs help improve awareness explaining the importance of sleep in many countries.
Narcolepsy (Central Nervous System) - Drugs In Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Narcolepsy - Drugs In Development, 2021, provides an overview of the Narcolepsy (Central Nervous System) pipeline landscape.Narcolepsy is a sleep disorder that...
The World Health Organization (WHO) made the following statement many years ago, “There is no health without mental health”.Today, as the COVID-19 pandemic ravages the world, another public health crisis is looming over our health systems—that of deteriorating mental health.
Mass unemployment, salary reductions, depleting financial...
120 pages •
By Infiniti Research Limited
• Jun 2021
Global Central Nervous System Disorders Therapeutics Market 2021-2025 The analyst has been monitoring the central nervous system disorders therapeutics market and it is poised to grow by $ 24.35 bn during 2021-2025, progressing at a CAGR of 4.44% during the forecast period. Our report on the central nervous system disorders...
The global behavioral health software market is expected to reach USD 4.9 billion by 2026 from USD 2.0 billion in 2021, at a CAGR of 19.6% during the forecast period. The major factors driving the growth of behavioral health software are the increasing adoption of behavioral health software, availability of government funding, government initiatives...
107 pages •
By Asia Market Information & Development Company
• Aug 2021
This study focuses on China’s Mental Illness Drugs industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China...
As people learn to embrace uncertainty, the top trends outlined at the beginning of 2021 will bring about significant changes in the way societies work and live. Changes in user behavior patterns will trigger major growth opportunities influenced by changes in consumption and business models.Emerging advancements in technologies, such as AI...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.